Levels of APE۱ Repair Gene and CLEC۴M in Lung Cancer Patients Receiving Cisplatin Chemotherapy
محل انتشار: مجله آرشیو رازی، دوره: 78، شماره: 3
سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 100
فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_ARCHRAZI-78-3_021
تاریخ نمایه سازی: 6 دی 1402
چکیده مقاله:
This study aimed to detect the levels of apurinic/apyrimidinic endonuclease ۱ (APE۱) gene expression and C-type lectin domain family ۴ member M (CLEC۴M) and their association with cisplatin chemotherapy in lung cancer patients. Overall, ۱۰۵ individuals who attended the Al-Amal National Hospital for Cancer Management, Baghdad, Iraq, were enrolled in the study and divided into three equal groups. The groups included the patients newly diagnosed with lung cancer, cancer patients who received cisplatin, and the healthy control group. All study groups were subjected to the sampling of the venous blood for molecular analysis by real-time polymerase chain reaction (RT-PCR) to detect the APE۱ gene and enzyme-linked immunosorbent assay (ELISA) for serological testing to measure the concentration of CLEC۴M protein. Significantly, the values of both cancer groups were higher than those reported in the control group. The relative index revealed a significant difference in the mean fold change level of APE۱ in the newly diagnosed group (۳ fold) and cisplatin therapy patients group (۲ fold), compared to the control group (P=۰.۰۰۵). No significant differences were detected between the two cancer groups in terms of fold change mean of expression, demographic characteristics, and cancer histological type. Regarding human CLEC۴M protein level, cases receiving cisplatin (۱۳۹.۲±۲۵.۹) and newly diagnosed patients (۳۳۱.۰±۳۸.۱) had a highly significant difference with the control group (۱۰۰.۳±۴۷.۵, P<۰.۰۰۱). There was no significant difference between the concentration level of CLEC۴M and all parameters in demographic characteristics and cancer histological type. This was the first study to demonstrate that higher expression levels of new APE۱, CLEC۴M, and glutathione, especially after chemotherapy, are beneficial as diagnostic and prognostic markers for resistance to platinum chemotherapy in Iraqi lung cancer patients.
کلیدواژه ها:
Apurinic/Apyrimidinic Endonuclease ۱ ، Cisplatin ، C-Type Lectin Domain family ۴ Member M ، Platinum chemotherapy
نویسندگان
Y. M. I Al-Mohammed Amin
Department of Clinical Laboratory Sciences, College of Pharmacy, Mustansiriyah University, Baghdad, Iraq
S Faisal Hatem Al-Mugdadi
Department of Clinical Laboratory Sciences, College of Pharmacy, Mustansiriyah University, Baghdad, Iraq
M Mahmood Mohammed
Department of Clinical Pharmacy , College of Pharmacy, Mustansiriyah University, Baghdad, Iraq
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :